Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro
about
Barrier requirements as the evolutionary "driver" of epidermal pigmentation in humansRe-appraisal of current theories for the development and loss of epidermal pigmentation in hominins and modern humansEvidence that stress to the epidermal barrier influenced the development of pigmentation in humansPreparation of water-soluble melanin from squid ink using ultrasound-assisted degradation and its anti-oxidant activity.Production and cytotoxicity of extracellular insoluble and droplets of soluble melanin by Streptomyces lusitanus DMZ-3.Epidermal permeability barrier recovery is delayed in vitiligo-involved sitesThe contribution of melanin to microbial pathogenesis.Actinobacterial melanins: current status and perspective for the future.Bioproduction, characterization, anticancer and antioxidant activities of extracellular melanin pigment produced by newly isolated microbial cell factories Streptomyces glaucescens NEAE-H.Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.Effect of biotransformation by liver S9 enzymes on the mutagenicity and cytotoxicity of melanin extracted from Aspergillus nidulans.Pharmacological Properties of Melanin and its Function in Health.A dark cuticle allows higher investment in immunity, longevity and fecundity in a beetle upon a simulated parasite attack.Homogentisic acid and structurally related compounds as intermediates in plasma soluble melanin formation and in tissue toxicities.Melanomacrophage functions in the liver of the caecilian Siphonops annulatus.Optimization of melanin production by Brevundimonas sp. SGJ using response surface methodology.Comparison of Antioxidant Activities of Melanin Fractions from Chestnut Shell
P2860
Q24624475-55D7FBE4-0AF4-45E7-8630-60DC77BF3BB9Q28703861-59457A76-D058-4627-BD9A-9223E23FA5A0Q28748361-94FE8608-CEF3-49EA-BD96-DEF849725F14Q30874663-6425B5E4-6E92-4C3F-ABAD-12F9CC693C17Q33563115-05AD31E3-53E0-408E-9DFE-DE3928259616Q33906546-9CB08827-1833-4183-84A6-70014A159E28Q35098810-0CFC3473-E251-4C74-9F3F-8F9673E1A5A7Q38099783-013F48B1-8BBE-4950-8751-9487C96F1137Q38716561-C7AF5D2D-9D13-43C9-8A1F-89C5A9DE8AE0Q38721811-07E439DB-90FF-4C79-8393-D156248FF0F4Q38828475-AA3561DC-89FD-407A-8680-8A3D77F4E23AQ39058786-554BC172-7511-48D0-9FFE-2981931E93D9Q39721893-250122B6-6124-4237-8FD7-84DAED74E90EQ42283059-14F8F91F-0B61-4CCA-A9CD-1D8E8DE187D7Q46248023-87CE5295-D637-41E0-8B66-6E16820B1033Q54120566-B0F84802-CD30-45EA-9BE8-293C579B5C55Q56084096-F315B952-6C4F-424E-9058-E2512933D14F
P2860
Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@ast
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@en
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@nl
type
label
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@ast
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@en
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@nl
prefLabel
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@ast
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@en
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@nl
P1433
P1476
Selective antiviral activity o ...... mmunodeficiency virus in vitro
@en
P2093
D C Montefiori
P356
10.1016/0166-3542(91)90037-R
P407
P577
1991-01-01T00:00:00Z